About Annovis Bio (ANVS)
Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsyl... Read more
- USD10.17
- USD11.74
- USD10.10
- USD22.49
- 1.60%
- --
- 36.00
- 189.82k
- 111M
- 5.42
- -27.30%
Stock News
3 hours ago
Forget SoundHound AI: 3 Tech Stocks to Buy Instead
Yahoo
3 hours ago
This Is Hands Down My Pick for the Best "Magnificent Seven" Stock Right Now. (Hint: It's Not Nvidia.)
Yahoo
4 hours ago
Swipe Right on Safety: New Study from Norton Finds 64% of Online Daters are Interested in Using AI as a Dating Coach
Yahoo
4 hours ago
JD Sports Fashion Buys Hibbett, Valuing It at $1.1 Bln, in Push Into U.S. Market
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
